veletri
actelion registration ltd - epoprostenol - pdr for soln for infusion - 0.5 milligram - epoprostenol
veletri
actelion registration ltd - epoprostenol - pdr for soln for infusion - 1.5 milligram - epoprostenol
heparin sodium bp 1000 iu/l in 0.9% w/v sodium chloride iv infusion
baxter holding b.v. - heparin sodium ; sodium chloride; disodium phosphate dodecahydrate; citric acid monohydrate - solution for infusion - 1000 iu/l + 0.9 percent weight/volume - heparin group; heparin
heparin sodium bp 2000 iu/l in 0.9 % w/v sodium chloride iv infusion
baxter holding b.v. - heparin sodium ; sodium chloride; disodium phosphate dodecahydrate; citric acid monohydrate - solution for infusion - 2000 iu/l + 0.9 percent weight/volume - heparin group; heparin
baxter heparin sodium 2000iu 1000ml injection ahb0944a
baxter healthcare pty ltd - heparin sodium, quantity: 2000 iu/l - injection, solution - excipient ingredients: water for injections; sodium chloride; citric acid monohydrate; dibasic sodium phosphate dodecahydrate - indications as at 11 july 2003: heparin sodium in 0.9% sodium chloride intravenous infusion is indicated as an anticoagulant in extracorporeal circulation, dialysis procedures, and as an aid in the maintenance of catheter patency.
baxter heparin sodium 1000iu 500ml injection ahb0953a
baxter healthcare pty ltd - heparin sodium, quantity: 1000 iu/l - injection, solution - excipient ingredients: sodium chloride; citric acid monohydrate; dibasic sodium phosphate dodecahydrate; water for injections - indications as at 11 july 2003: heparin sodium in 0.9% sodium chloride intravenous infusion is indicated as an anticoagulant in extracorporeal circulation, dialysis procedures, and as an aid in the maintenance of catheter patency.
monoparin or heparin sodium 1,000iu/ml solution for injection or conc for solution for infusion
pinewood laboratories limited ballymacarbry, clonmel, co. tipperary, ireland - heparin sodium - solution for injection concentrate for solution for infusion - heparin sodium 1000 iu/ml - antithrombotic agents
veletri 1.5 milligram powder for solution for infusion
janssen-cilag international nv - epoprostenol - powder for solution for infusion - 1.5 milligram(s) - platelet aggregation inhibitors excl. heparin; epoprostenol
veletri 0.5 milligram powder for solution for infusion
janssen-cilag international nv - epoprostenol - powder for solution for infusion - 0.5 milligram(s) - platelet aggregation inhibitors excl. heparin; epoprostenol
epoprostenol teva ® 1.5 mg
salomon,levin & elstein ltd - epoprostenol as sodium 1.5 mg - powder and solvent for solution for infusion - epoprostenol - epoprostenol teva is indicated for the long-term intravenous treatment of primary arterial pulmonary hypertension and arterial pulmonary hypertension associated with the scleroderma spectrum of disease in nyha class iii and class iv patients who do not respond to conventional therapy.